- Transcept/Purdue plan new campaign to wake up lackluster Intermezzo sales
- Lilly's Cialis wins BPH extension in EU
- Vivus prices $220m private placement
- First Manhattan seeks 2nd successful life science turnaround with Vivus nominees
ONLY 0 DAY LEFT
|Stay close to your market. Renew online now to ensure uninterrupted access to:|
|SCRIP Intelligence's news and expert commentary|
|Market Data and Company Analysis (SCRIP 100, SCRIP Asia 100)|
|The Ask the Analyst Service...and more.|
Please remember to quote your order number and customer number.
You can also renew by calling: +44 (0)20 7017 5540.